Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on March 23, 2026

Mar. 23, 2026

Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test

Indeterminate GlobeNewswire

Mar. 23, 2026

Vantive Accelerates U.S. Home Therapy Transformation With New Digital and Patient Support Innovations

Indeterminate GlobeNewswire

Mar. 23, 2026

SafeSpace Global Secures Shareholder Approval to Increase Authorized Shares of Common Stock

Indeterminate GlobeNewswire

Mar. 23, 2026

Cortexa Advances Commercialisation of MDMA Supply in Australia

Indeterminate GlobeNewswire

Mar. 23, 2026

China SXT Pharmaceuticals, Inc. Announces Share Re-classification

Indeterminate GlobeNewswire

Mar. 23, 2026

Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference

Indeterminate GlobeNewswire

Mar. 23, 2026

Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout

Indeterminate GlobeNewswire

Mar. 23, 2026

Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group

Indeterminate GlobeNewswire

Mar. 23, 2026

Bicara Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Business Updates on March 30, 2026, at 8:30 AM ET

Indeterminate GlobeNewswire

Mar. 23, 2026

NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

Indeterminate GlobeNewswire

Mar. 23, 2026

Onconetix, Inc. Announces 1-for-5 Reverse Stock Split

Indeterminate GlobeNewswire

Mar. 23, 2026

RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement

Indeterminate GlobeNewswire

Mar. 23, 2026

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

Indeterminate GlobeNewswire

Mar. 23, 2026

TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus

Indeterminate GlobeNewswire

Mar. 23, 2026

Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults

Indeterminate GlobeNewswire

Mar. 23, 2026

Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

Indeterminate GlobeNewswire

Mar. 23, 2026

Inspire and HPV Cancers Alliance Launch New Online Community for People Affected by HPV-Related Cancers

Indeterminate GlobeNewswire

Mar. 23, 2026

NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™

Indeterminate GlobeNewswire

Mar. 23, 2026

MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer

Indeterminate GlobeNewswire

Mar. 23, 2026

NÖK Therapeutics to Present Long-Term Clinical Data at the 11th Annual Innate Killer Summit

Indeterminate GlobeNewswire